Digital Library
Close Browse articles from a journal
 
<< previous    next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 127 of 185 found articles
 
 
  Patient-reported outcomes (PROs) of cemiplimab (CEMI) versus platinum-doublet chemotherapy (chemo) in advanced non-small cell lung cancer (aNSCLC) with programmed cell death-ligand 1 (PD-L1) ≥50%: A focus on EMPOWER-Lung 1 (NCT03088540) age subgroups
 
 
Title: Patient-reported outcomes (PROs) of cemiplimab (CEMI) versus platinum-doublet chemotherapy (chemo) in advanced non-small cell lung cancer (aNSCLC) with programmed cell death-ligand 1 (PD-L1) ≥50%: A focus on EMPOWER-Lung 1 (NCT03088540) age subgroups
Author: Gogishvili, M.
Kilickap, S.
Sezer, A.
Gümüş, M.
Bondarenko, I.
Özgüroğlu, M.
He, X.
Gullo, G.
Rietschel, P.
Quek, R.G.W.
Appeared in: Journal of geriatric oncology
Paging: Volume 13 () nr. 8S1 pages S3
Year: 2022
Contents:
Publisher: Elsevier Ltd.
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 127 of 185 found articles
 
<< previous    next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands